We previously observed that aquaporin-3 and aquaporin-10 are upregulated in the epidermis of hand dermatitis patients (Med. Hypotheses, 84, 2015, 498). To address the functional relevance of this upregulation, we overexpressed AQP3/AQP10 in mice using the human k1 promoter.
| BACKGROUND
Despite increased insights regarding the immunobiology of atopic dermatitis (AD) and dermatitis in general, these diseases remain chronic, incurable afflictions whose underlying pathogenesis is poorly understood but appears exacerbated by humidity gradients. [1] Indeed, in quality-of-life measures, dermatitis (AD and others) is more debilitating than psoriasis and non-melanoma skin cancer [2] and accounts for up to $3.8 billion uS dollars in annual care. [3] However, the exact cause of these conditions remains incomplete. One of the underlying mechanisms involved in sustaining AD and dyshidrosis is the increase in transepidermal water loss (TEWL). TEWL is the loss of water via the skin. Aquaporins are membrane channel proteins that increase the permeability of cell membranes to the bidirectional, osmotically driven passage of small uncharged molecules, including water, glycerol and urea. Interestingly, recent publications have shown that aquaporin-3 (AQP3) and aquaporin-10 (AQP10) are the main aquaglyceroporins expressed in human keratinocytes. [4, 5] In healthy skin, AQP3 expression has been reported to be low, with the majority of expression in the stratum basale, [4] although others have observed AQP3 expression in suprabasal keratinocytes as well, see supplementary references s1-4. In atopic dermatitis patients, AQP3 expression was reportedly increased in both the stratum basale and the stratum spinosum, potentially contributing to the increase in TEWL. AQP3 overexpression in keratinocytes has also been shown to promote proliferation. [6] Interestingly, uVB-treated skin, therapeutic for AD, exhibits a decrease in AQP3 expression. [7] Finally, AQP3 water and glycerol conducting properties are activated by water and inhibited in an acidic environment (pH<7), which constitutes the normal pH in the stratum corneum of healthy skin.
| QUESTIONS ADDRESSED
We previously demonstrated the overexpression of AQP3 and AQP10 protein in human eczematous as compared to healthy skin [8] corroborating previous studies measuring AQP3. [4] [5] [6] These findings are consistent with inflammatory skin models in mice whereby increased AQP3 expression was found after ovalbumin or oxazolone challenge. [6] The functional relevance of augmented AQP3 expression in these inflammatory settings was unclear. We hypothesized that overexpression of AQP3±AQP10 may contribute to the severity and/or chronicity of inflammatory skin disease. Therefore, we overexpressed epidermal aquaporins in mice similar to the levels found in human skin disease states to determine their contribution to overall disease metrics (weight loss, skin thickening and skin differentiation).
| EXPERIMENTAL DESIGN
We overexpressed murine AQP3 (the major epidermal aquaporin) as well as human AQP10 (exclusive to human skin) in the epidermis of mice, using the human k1 promoter ( Figure 1A ,B, respectively). using primers specific to spliced mRNAs of AQP3 and AQP10, we confirmed mRNA overexpression of AQP3 and APQ10 ( Figure 1C ). We then observed Mendelian rations of both single-and double-transgenic mice using primers specific to the transgenic DNA constructs of both AQP3
and AQP10 ( Figure 1D ). Corresponding protein overexpression in the epidermis was determined by immunofluorescent microscopy (Fig.   S1 ). These mice were than examined for overall weight loss, acanthosis and epidermal differentiation of keratinocytes. We employed a variation of the imiquimod mouse model which cannot exactly recapitulate human pathologies such as AD and psoriasis but has been very well characterized and can still provide valuable insights into these human diseases.
| RESULTS
We measured daily weights of WT and aquaporin-overexpressing mice during imiquimod challenge for 5 days followed by 4 days of detergent-containing water challenge.
We observed that single AQP3 overexpression as well as AQP3×AQP10 overexpression resulted in a trend towards greater weight loss, but did not meet statistical significance (Figure 2A,B) . As the skin differentiation markers filaggrin, k10 and loricrin are important for proper skin barrier function, we evaluated the expression of these proteins and transcripts. We observed a blunting of water-based induction of filaggrin upon immunohistochemical staining (Fig. S3A,B,G) . No statistically significant difference in mRNA expression of filaggrin, k10 or loricrin was found using RT-qPCR ( of these factors is diagrammed in Fig. S4 .
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